Inderal

Propranolol, the active ingredient in Inderal, is a beta blocker presented as an oral tablet for oral use. It is employed to manage high blood pressure, angina pectoris, cardiac arrhythmias, myocardial infarction prophylaxis, migraine prevention, and essential tremor in adult patients under medical supervision and is prescribed by qualified healthcare professionals in various therapeutic settings.

GNH USA supplies Inderal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and transplant centres worldwide through regulated distribution channels.

Inderal, a non‑selective beta‑adrenergic antagonist, is used in several cardiovascular and neurological conditions: - Hypertension: lowers blood pressure by reducing cardiac output and inhibiting renin release. - Angina pectoris: decreases myocardial oxygen demand, relieving chest pain. - Cardiac arrhythmias: stabilises heart rhythm by slowing conduction through the AV node. - Myocardial infarction prophylaxis: reduces risk of recurrent heart attacks after an initial event. - Migraine prophylaxis: prevents migraine attacks by modulating vascular tone. - Essential tremor: diminishes tremor amplitude through central beta‑blockade.

Common Side Effects: - Fatigue or tiredness. - Dizziness or light‑headedness. - Cold hands and feet. - Gastrointestinal upset such as nausea or abdominal discomfort. - Sleep disturbances, including vivid dreams. - Mild bradycardia.

Serious or Rare Side Effects: - Severe bradycardia or heart block. - Marked hypotension. - Bronchospasm, especially in patients with asthma or COPD. - Acute heart failure exacerbation. - Hypoglycaemia unawareness in diabetic patients. - Depression or mood changes.

Before initiating Inderal, consider the following precautions: - Cardiovascular assessment: evaluate heart rate and blood pressure to ensure suitability. - Respiratory conditions: avoid in patients with active asthma or severe COPD due to risk of bronchospasm. - Diabetes monitoring: beta‑blockade may mask hypoglycaemia symptoms; monitor glucose closely. - Discontinuation: taper gradually to prevent rebound hypertension or tachycardia. - Pregnancy and lactation: use only if potential benefits outweigh risks. - Store at ambient temperature: keep below 25 °C, protect from moisture and light in the original container.

Propranolol may interact with several medicines; monitor as indicated: Major Interactions (Avoid): - Co‑administration with other bradycardic agents (e.g., verapamil, diltiazem) can cause severe heart block. - Combined use with insulin or sulfonylureas may mask hypoglycaemia signs. - Potent CYP2D6 inhibitors (e.g., quinidine) can raise propranolol plasma levels. Moderate Interactions (Monitor Closely): - Concurrent antihypertensives may enhance hypotensive effects. - Certain antidepressants (e.g., SSRIs) may require dose adjustments. - NSAIDs can attenuate the antihypertensive efficacy of propranolol.